These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29228516)

  • 1. Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.
    Kautzky A; Dold M; Bartova L; Spies M; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29228516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Prediction Model for Evaluating Treatment-Resistant Depression.
    Kautzky A; Baldinger-Melich P; Kranz GS; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2017 Feb; 78(2):215-222. PubMed ID: 28068461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.
    Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
    Acta Psychiatr Scand; 2019 Jan; 139(1):78-88. PubMed ID: 30291625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
    Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
    JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1.
    Nunez JJ; Nguyen TT; Zhou Y; Cao B; Ng RT; Chen J; Frey BN; Milev R; Müller DJ; Rotzinger S; Soares CN; Uher R; Kennedy SH; Lam RW
    PLoS One; 2021; 16(6):e0253023. PubMed ID: 34181661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
    Pettorruso M; Guidotti R; d'Andrea G; De Risio L; D'Andrea A; Chiappini S; Carullo R; Barlati S; Zanardi R; Rosso G; De Filippis S; Di Nicola M; Andriola I; Marcatili M; Nicolò G; Martiadis V; Bassetti R; Nucifora D; De Fazio P; Rosenblat JD; Clerici M; Maria Dell'Osso B; Vita A; Marzetti L; Sensi SL; Di Lorenzo G; McIntyre RS; Martinotti G;
    Psychiatry Res; 2023 Sep; 327():115378. PubMed ID: 37574600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
    Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
    J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
    Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression.
    Wu B; Cai Q; Sheehan JJ; Benson C; Connolly N; Alphs L
    PLoS One; 2019; 14(8):e0220763. PubMed ID: 31393922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.
    Balestri M; Calati R; Souery D; Kautzky A; Kasper S; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2016 Jan; 189():224-32. PubMed ID: 26451508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.
    Murrough JW; Wade E; Sayed S; Ahle G; Kiraly DD; Welch A; Collins KA; Soleimani L; Iosifescu DV; Charney DS
    J Affect Disord; 2017 Aug; 218():277-283. PubMed ID: 28478356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response.
    Johnson KM; Devine JM; Ho KF; Howard KA; Saretsky TL; Jamieson CA
    J Clin Psychiatry; 2016 Dec; 77(12):1681-1686. PubMed ID: 28086004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Machine Learning help us in dealing with treatment resistant depression? A review.
    Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
    J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
    Souery D; Oswald P; Massat I; Bailer U; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Serretti A; Zohar J; Mendlewicz J;
    J Clin Psychiatry; 2007 Jul; 68(7):1062-70. PubMed ID: 17685743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age as a moderating factor of treatment resistance in depression.
    Kautzky A; Bartova L; Fugger G; Dold M; Souery D; Montgomery S; Zohar J; Mendlewicz J; Fabbri C; Serretti A; Rujescu D; Kasper S
    Eur Psychiatry; 2023 Apr; 66(1):e35. PubMed ID: 37078509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review.
    De Carlo V; Calati R; Serretti A
    Psychiatry Res; 2016 Jun; 240():421-430. PubMed ID: 27155594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
    Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH
    J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a machine learning approach to investigate factors associated with treatment-resistant depression among adults with chronic non-cancer pain conditions and major depressive disorder.
    Shah D; Zheng W; Allen L; Wei W; LeMasters T; Madhavan S; Sambamoorthi U
    Curr Med Res Opin; 2021 May; 37(5):847-859. PubMed ID: 33686881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.